Retec Formulations Private Limited, a active private limited company, was established on 09 February 1998 in New Delhil, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U33110DL1998PTC092158. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.75 M.
It upholds a compliant status. Its leadership includes Anjani Kumar Pandey (Director), Suvidha Pandey (Director). Past directors included Suman Lata Gupta. It holds ₹1.33 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-25/5 Connaught Place, New Delhil, Delhi, 110001.
U33110DL1998PTC092158
092158
09 February 1998
₹1.00 M
₹0.75 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Retec Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anjani Kumar Pandey | Director | 09 Feb 1998 | Current |
| Suvidha Pandey | Director | 09 Feb 1998 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Nov 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Retec Formulations Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 32.03% increase in profit. The company's net worth observed a substantial decline by a decrease of 80.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Retec Formulations had a public holding of 6.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹13,300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 May 2013 | Oriental Bank Of Commerce | ₹1.10 M | Open |
| 01 Mar 2006 | Others | ₹1.20 Cr | Open |
| 16 Jun 1999 | Oriental Bank Of Commerce | ₹0.20 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Retec Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Retec Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Retec Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Retec Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Retec Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on A charge with Others of Rs. 12.00 M registered on 01 Mar 2006 with Charge ID 10002069 was modified on 20 Jun 2017. was documented.
The activity A charge with Oriental Bank Of Commerce amounted to Rs. 1.10 M with Charge ID 10428948 was registered on 14 May 2013. was completed.
A charge with Others amounted to Rs. 12.00 M with Charge ID 10002069 was registered on 01 Mar 2006. was recorded as a recent event.
Progress on A charge with Oriental Bank Of Commerce of Rs. 0.20 M registered on 16 Jun 1999 with Charge ID 90368429 was modified on 20 Aug 2000. was documented.
The CIN of Retec Formulations Private Limited is U33110DL1998PTC092158.
Retec Formulations Private Limited is headquartered at C-25/5 Connaught Place, New Delhil, Delhi, 110001.
Retec Formulations Private Limited was incorporated on 09 February 1998.
The current directors of Retec Formulations Private Limited are
The primary industry of Retec Formulations Private Limited is Trade.
Retec Formulations Private Limited is unlisted.
The authorized capital of Retec Formulations Private Limited is ₹1.00 M, and the paid-up capital is ₹0.75 M.
The compliance status of Retec Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX